Sutro Biopharma, Inc. (STRO)
21.39
+0.90
(+4.39%)
USD |
NASDAQ |
Aug 25, 16:00
21.39
0.00 (0.00%)
After-Hours: 19:59
Sutro Biopharma Total Assets (Quarterly) : 194.46M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 194.46M |
| March 31, 2026 | 241.99M |
| December 31, 2025 | 173.83M |
| September 30, 2025 | 209.66M |
| June 30, 2025 | 262.36M |
| March 31, 2025 | 321.43M |
| December 31, 2024 | 387.21M |
| September 30, 2024 | 451.83M |
| June 30, 2024 | 489.04M |
| March 31, 2024 | 403.40M |
| December 31, 2023 | 470.74M |
| September 30, 2023 | 431.73M |
| June 30, 2023 | 464.90M |
| March 31, 2023 | 358.02M |
| December 31, 2022 | 406.94M |
| September 30, 2022 | 400.70M |
| June 30, 2022 | 385.62M |
| March 31, 2022 | 303.68M |
| Date | Value |
|---|---|
| December 31, 2021 | 341.41M |
| September 30, 2021 | 371.47M |
| June 30, 2021 | 359.79M |
| March 31, 2021 | 358.53M |
| December 31, 2020 | 394.11M |
| September 30, 2020 | 307.24M |
| June 30, 2020 | 277.54M |
| March 31, 2020 | 153.88M |
| December 31, 2019 | 156.37M |
| September 30, 2019 | 171.68M |
| June 30, 2019 | 188.81M |
| March 31, 2019 | 202.46M |
| December 31, 2018 | 223.14M |
| September 30, 2018 | 145.03M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 40.98M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 1.390B |
| Upstream Bio, Inc. | 281.17M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 297.78M |
| Shareholders Equity (Quarterly) | -103.32M |
| Debt to Equity Ratio | -2.418 |
| Current Ratio | 3.320 |
| Net Debt Paydown Yield | -1.39% |